News Focus
News Focus
Followers 74
Posts 15870
Boards Moderated 0
Alias Born 04/26/2010

Re: north40000 post# 140446

Tuesday, 09/04/2018 3:05:55 PM

Tuesday, September 04, 2018 3:05:55 PM

Post# of 447692
I disagree strongly, and frankly cannot understand why folks aren't reading this correctly and using some knowledge and common sense - 1st A is about what AMRN reps can say (only) to docs:

Amarin “bears the responsibility, going forward, of assuring that its communications to doctors regarding off-label use of Vascepa remain truthful and non-misleading.”




Think about all of the BPs that were fined billions for off-label promotions that turned out badly, like promoting TO DOCTORS that adolescents be prescribed anti-depressants that had no pediatric indication, leading so many suicides - those drugs were never promoted to consumers for that use.

I could go back and read the court filings to prove AMRN was seeking to promote off-label to doctors only, but it's not worth the time it would take. Pacira's case was also about what they could promote to surgeons.

The Thought Police: To censor and protect. Craig Bruce

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News